These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5627797)

  • 21. A ten year review of colomycin.
    Littlewood JM; Koch C; Lambert PA; Høiby N; Elborn JS; Conway SP; Dinwiddie R; Duncan-Skingle F
    Respir Med; 2000 Jul; 94(7):632-40. PubMed ID: 10926333
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cefoperazone in infections caused by resistant agents, with special reference to Pseudomonas aeruginosa].
    Torres A; Vega J; Aguirre M; Alés JM
    Rev Clin Esp; 1982 Feb; 164(4):229-32. PubMed ID: 6211752
    [No Abstract]   [Full Text] [Related]  

  • 23. The treatment of bacterial infections in the newborn infant.
    Dashefsky B; Klein JO
    Clin Perinatol; 1981 Oct; 8(3):559-77. PubMed ID: 7030577
    [No Abstract]   [Full Text] [Related]  

  • 24. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 25. [Isolation and identification of a strain of Pseudomonas putrefaciens].
    Sanchis-Bayarri Vaillant V; Sanchis-Bayarri Lahoz V
    Rev Clin Esp; 1981 Apr; 161(2):119-20. PubMed ID: 7280316
    [No Abstract]   [Full Text] [Related]  

  • 26. [Susceptibility of Pseudomonas aeruginosa isolated from hospital infections to antibiotics].
    Gniadkowski M; Skoczyńska A; Fiett J; Trzciński K; Hryniewicz W
    Pol Merkur Lekarski; 1998 Dec; 5(30):346-50. PubMed ID: 10101521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measurement of increasing antibiotic-resisnce in cases of bacterial synergism due to mixed pseudomonas and enteroccocus infections].
    Pérez-Ureña MT; Iriarte MT
    Rev Clin Esp; 1969 Jun; 113(5):435-40. PubMed ID: 5800550
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibiotic treatment in otorhinolaryngology].
    Feldmann H; Bräunig M
    Dtsch Med J; 1972 Apr; 23(4):315-8. PubMed ID: 5044189
    [No Abstract]   [Full Text] [Related]  

  • 29. [Guidelines for fighting penicillin resistant agents in the ear-nose-throat area].
    Schaal KP
    HNO; 1970 Apr; 18(4):105-11. PubMed ID: 4987429
    [No Abstract]   [Full Text] [Related]  

  • 30. Ventilator-associated pneumonia caused by Pseudomonas infection.
    Dunn M; Wunderink RG
    Clin Chest Med; 1995 Mar; 16(1):95-109. PubMed ID: 7768096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antibacterial activity of aminoglycoside antibiotics against Pseudomonas strains.
    Panse MV; Nair KR
    Hindustan Antibiot Bull; 1981; 23():30-2. PubMed ID: 7309552
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mechanisms of resistance in Pseudomonas aeruginosa].
    Cercenado Mansilla E; García Garrote F
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():10-6. PubMed ID: 9844472
    [No Abstract]   [Full Text] [Related]  

  • 33. [Study on the type of bacteria isolated from oto-rhino-pharyngo-laryngological diseases and their sensitivity to antibiotics].
    Sakai M; Ida M
    Iryo; 1968 Jul; 22(7):853-7. PubMed ID: 5702017
    [No Abstract]   [Full Text] [Related]  

  • 34. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.
    Mohr JF; Jones A; Ostrosky-Zeichner L; Wanger A; Tillotson G
    Int J Antimicrob Agents; 2004 Oct; 24(4):346-51. PubMed ID: 15380259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sensitivity to antibiotics and staphylococcal phages isolated in ENT diseases].
    Gerasimenko DD; Pavlova VA; Danileĭko LV; Markelova AM
    Mikrobiol Zh (1978); 1981; 43(6):786-90. PubMed ID: 6460162
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
    Matinca D; Vancea D; Boboş C; Serban O
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
    Zavascki AP
    Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
    [No Abstract]   [Full Text] [Related]  

  • 38. Contemporary antibiotic therapy in otolaryngology.
    Neu HC
    Otolaryngol Clin North Am; 1984 Nov; 17(4):745-60. PubMed ID: 6542638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
    Harbarth S; Harris AD; Carmeli Y; Samore MH
    Clin Infect Dis; 2001 Nov; 33(9):1462-8. PubMed ID: 11588690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
    Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
    Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.